Portage Biotech Statistics
Share Statistics
Portage Biotech has 1.12M
shares outstanding. The number of shares has increased by -94.33%
in one year.
| Shares Outstanding | 1.12M |
| Shares Change (YoY) | -94.33% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 10.71% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 55,082 |
| FTD / Avg. Volume | 3.97% |
Short Selling Information
The latest short interest is 131.85K, so 8.01% of the outstanding
shares have been sold short.
| Short Interest | 131.85K |
| Short % of Shares Out | 8.01% |
| Short % of Float | 10.12% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -2.99 and the forward
PE ratio is -1.15.
Portage Biotech's PEG ratio is
0.07.
| PE Ratio | -2.99 |
| Forward PE | -1.15 |
| PS Ratio | 0 |
| Forward PS | 4.8 |
| PB Ratio | 55.93 |
| P/FCF Ratio | -15.74 |
| PEG Ratio | 0.07 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Portage Biotech.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.67,
with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.67 |
| Quick Ratio | 2.67 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -570.41 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-10,762,714.29 |
| Employee Count | 7 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -10.55M |
| Effective Tax Rate | 12.31% |
Stock Price Statistics
The stock price has increased by 106.92% in the
last 52 weeks. The beta is 0.97, so Portage Biotech's
price volatility has been higher than the market average.
| Beta | 0.97 |
| 52-Week Price Change | 106.92% |
| 50-Day Moving Average | 6.17 |
| 200-Day Moving Average | 5.13 |
| Relative Strength Index (RSI) | 61.98 |
| Average Volume (20 Days) | 1,388,603 |
Income Statement
| Revenue | n/a |
| Gross Profit | -54K |
| Operating Income | -18.25M |
| Net Income | -75.34M |
| EBITDA | -18.2M |
| EBIT | -18.25M |
| Earnings Per Share (EPS) | -3.7 |
Full Income StatementBalance Sheet
The company has 5.03M in cash and 47K in
debt, giving a net cash position of 4.98M.
| Cash & Cash Equivalents | 5.03M |
| Total Debt | 47K |
| Net Cash | 4.98M |
| Retained Earnings | -239.32M |
| Total Assets | 2.71M |
| Working Capital | 1.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -14.3M
and capital expenditures 0, giving a free cash flow of -14.3M.
| Operating Cash Flow | -14.3M |
| Capital Expenditures | n/a |
| Free Cash Flow | -14.3M |
| FCF Per Share | -0.7 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
